Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.

IF 0.9 4区医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Hellenic journal of nuclear medicine Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI:10.1967/s002449912600

M Koutelou, V Prassopoulos, L Lamprakos, A Zissimopoulos, T Chatzipanagiotou, A Mastorakou, A Doumas

引用次数: 0

Abstract

Cardiac amyloidosis is a rare condition characterized by the accumulation of abnormal proteins called amyloids in the heart tissue. These amyloids can disrupt the normal functioning of the heart and lead to a variety of symptoms and complications.

查看原文本刊更多论文

希腊核心脏病学会批准的核医学从业人员关于 ATTR 心脏淀粉样变性患者无创诊断的立场声明。

心脏淀粉样变性是一种罕见的疾病，其特征是心脏组织中积聚称为淀粉样蛋白的异常蛋白质。这些淀粉样蛋白会破坏心脏的正常功能，导致各种症状和并发症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hellenic journal of nuclear medicine 医学-核医学

CiteScore

1.40

自引率

6.70%

发文量

审稿时长

>12 weeks

期刊介绍： The Hellenic Journal of Nuclear Medicine published by the Hellenic Society of Nuclear Medicine in Thessaloniki, aims to contribute to research, to education and cover the scientific and professional interests of physicians, in the field of nuclear medicine and in medicine in general. The journal may publish papers of nuclear medicine and also papers that refer to related subjects as dosimetry, computer science, targeting of gene expression, radioimmunoassay, radiation protection, biology, cell trafficking, related historical brief reviews and other related subjects. Original papers are preferred. The journal may after special agreement publish supplements covering important subjects, dully reviewed and subscripted separately.